You are here

Our science / Clinical Trials / Find a Trial / NCT00768833

Study Evaluating the Nasopharyngeal Carriage in Healthy Children

Back to Search Print Save as PDF Bookmark Trial

NCT00768833

Last updated on May 10, 2018
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Offenbach, , 63069 Germany
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy Subjects
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
3-4 months
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Main inclusion criteria:

- Age at enrolment 3 to 4 month Main

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Malformation or injury of the nasopharynx

- Known or suspected immunodeficiency

- Relevant immunosuppression

- Use of antibiotics up to 10 days prior to study inclusion

NCT00768833
Pfizer
Completed
Study Evaluating the Nasopharyngeal Carriage in Healthy Children

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.
Advanced Search

Similar Trials

Healthy Volunteers
Single-dose Study of [14C]Lorlatinib (PF-06463922) Metabolism In Healthy Male Volunteers
NCT03184168
Males
18+
Years
Madison, Wisconsin
Healthy Volunteers
A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers
NCT03273842
All Genders
18+
Years
Multiple Sites
Healthy, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis
Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis
NCT02743871
All Genders
18+
Years
Multiple Sites
Healthy Volunteers
Bioavailability Study Comparing 10 Mg Amlodipine Besylate Orally Disintegrating Tablet (ODT) And 10 Mg Amlodipine Besylate Tablets
NCT01138826
All Genders
18+
Years
Hydrabad, Andhra Pradesh
Study Evaluating the Nasopharyngeal Carriage in Healthy Children
Nasopharyngeal Carriage in Children After Introduction of General Pneumococcal Immunization in Germany
The purpose of this study is to assess the prevalence of pneumococcal stereotypes in the nasopharynx of healthy children and to describe the changes of nasopharyngeal carriage at different ages over time.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
community sample
Healthy Subjects
Not Provided
Not Provided
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
242
August 2014
August 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

Main inclusion criteria:

  • Age at enrolment 3 to 4 month Main

Exclusion Criteria:

  • Malformation or injury of the nasopharynx
  • Known or suspected immunodeficiency
  • Relevant immunosuppression
  • Use of antibiotics up to 10 days prior to study inclusion
Sexes Eligible for Study: All
3 Months to 4 Months   (Child)
Yes
Contact information is only displayed when the study is recruiting subjects
Germany
 
 
NCT00768833
0887X1-4453
No
Not Provided
Not Provided
Pfizer
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
August 2014

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now